Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

  • This share is currently suspended. It was suspended at a price of 0.0026

Share Price Information for Supply@me Cap (SYME)

Share Price is delayed by 15 minutes
Get Live Data
0.0026    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £1.87m
SYME Live PriceLast checked at - London Stock Exchange

Intraday Supply@me Cap Share Chart

Update on first Inventory Monetisation Transaction

29 Jul 2022 07:00

RNS Number : 2255U
Supply @ME Capital PLC
29 July 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU, WHICH IS PART OF UNITED KINGDOM DOMESTIC LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

29 July 2022

 

Supply@ME Capital plc

(The "Company" or "SYME")

Update on inaugural Inventory Monetisation© transaction

 

Supply@ME Capital plc, the fintech business which provides an innovative Platform for use by manufacturing and trading companies to access Inventory Monetisation© solutions enabling their businesses to generate cashflow, is pleased to update the market with reference to the execution of the first official Inventory Monetisation ("IM") transaction.

This follows the announcement made by the Company on 28 June related to the strategic alliance ("Agreement") signed with VeChain Foundation[1] ("VeChain") aimed at launching the Web3[2] stream and funding up to USD $10m of IM transactions, leveraging the minting of dedicated Non-Fungible Tokens ("NFT") directly subscribed by VeChain.

SYME and VeChain worked closely in July to design the integration processes between their respective platforms. As of today, the IM transaction is in the final stage of its completion which will involve the coordination of the formal signing process of the following Parties:

· the Stock (trading) Company, as per the SYME Business Model Canvas outlined in the Company's Annual Report and Accounts for the year ended 31 December 2021, which will sign the commercial agreements with the Client Company to execute the IM transaction;

· VeChain Foundation, who in turn, signs the NFT purchase agreement with the Stock (trading) Company, in accordance with the binding commitment provided within the Agreement; and

· finally, the Company's Italian operating subsidiaries which sign the necessary service agreements with the Stock (trading) Company.

All Parties are fully committed to the formal completion of the IM transaction, following each parties final internal approval process which, with reference to the Client Company (a global manufacturer), is planned for next week.

The Company will provide further updates in due course, including details regarding the revenue impact of the IM transaction executed.

 

For the purposes of UK MAR, the person responsible for arranging release of this announcement on behalf of SYME is Alessandro Zamboni, CEO.

 

Contacts

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Paul Vann, Walbrook PR Limited, +44 (0)20 7933 8780; paul.vann@walbrookpr.com

Chris Wimpress, Cicero/AMO, +44 (0)79 7013 7527, chris.wimpress@cicero-group.com

Ed Saunders, Cicero/AMO, +44 (0)75 1017 4541, Edward.saunders@cicero-group.com

 

Notes

Supply@ME Capital PLC and its operating subsidiaries (together the "Group") provide an innovative fintech platform (the "Platform") for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt. This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders. The inventory to be monetised can include warehouse goods waiting to be sold to end-customers or goods/ commodities that are part of a typical import/ export transaction. SYME announced in August 2021 the launch of a global Inventory Monetisation programme which will be focused on both inventory in transit monetisation and warehoused goods monetisation. This programme will be focused on creditworthy companies and not those in distress or otherwise seeking to monetise illiquid inventories. 

 

 


[1] https://www.vechain.org/.

[2] According to Messari report "Crypto theses 2022", crypto, or the recently en vogue "Web3", is an unstoppable force in the long-term. Web3 is an all-encompassing term that captures cryptocurrencies (digital gold & stablecoins), smart contract computing (Layer 1-2 platforms), decentralized hardware infrastructure (video, storage, sensors, etc), Non-Fungible Tokens (digital ID & property rights), DeFi (financial services to swap and collateralize web3 assets), the Metaverse (the digital commons built in game-like environments), and community governance (DAOs, or decentralized autonomous organizations).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUWCMUPPUAB
Date   Source Headline
28th Apr 20267:00 amRNSExercise of Open Offer Warrants
27th Apr 20267:00 amRNSDelay in publishing 2025 Annual Financial Report
10th Apr 20267:00 amRNSExercise of Open Offer Warrants
16th Jan 20267:00 amRNSExercise of Open Offer Warrants
6th Jan 20267:00 amRNSProposed acquisition - Heads of Terms
19th Dec 20257:00 amRNSExercise of Open Offer Warrants
19th Dec 20257:00 amRNSExercise of Open Offer Warrants
5th Dec 202511:05 amRNSResults of AGM and Directorate Change
19th Nov 20257:00 amRNSBusiness update
6th Nov 20257:00 amRNSNotice of AGM
23rd Oct 20258:08 amRNSRestoration of Listing and Trading
23rd Oct 20257:30 amRNSRestoration - Supply@Me Capital plc
20th Oct 20257:00 amRNSFunding update
14th Oct 20257:00 amRNSH1 2025 unaudited interim report and accounts
13th Oct 20257:00 amRNS2024 Annual Report and Accounts
29th Sep 20257:00 amRNSDelay in publication of the H12025 interim results
18th Sep 20257:00 amRNSFunding update
15th Sep 20252:32 pmRNSFunding update
1st Sep 20257:00 amRNSFacility Amendment and Funding Update
31st Jul 20257:00 amRNSFunding update
16th Jul 20257:00 amRNSFunding update
2nd Jul 202512:00 pmRNSFunding update
24th Jun 20257:00 amRNSFunding update
11th Jun 20257:00 amRNSFacility Amendment and Funding Update
2nd Jun 20257:00 amRNSFunding Update
6th May 20257:00 amRNSPDMR Resignation
1st May 20257:00 amRNSFunding update
28th Apr 20257:00 amRNSDelay in published 2024 Annual Report and Accounts
1st Apr 202510:58 amRNSFunding update
19th Mar 20257:00 amRNSNew Funding Facility
14th Feb 20257:00 amRNSAppointment of new auditor
10th Feb 20257:00 amRNSFunding update
20th Jan 20257:00 amRNSDirector’s Other External Appointments
17th Dec 20247:00 amRNSBusiness Update
30th Sep 20242:45 pmRNSUnaudited interim results
25th Sep 20247:00 amRNSResignation of Auditor
6th Sep 20247:00 amRNSDirectorate Change
9th Jul 20247:00 amRNSExercise of Open Offer Warrants
28th Jun 20249:22 amRNSResult of AGM
31st May 202411:14 amRNSHolding(s) in Company
31st May 20247:00 amRNSTotal Voting Rights
29th May 20244:58 pmRNSNotice of Annual General Meeting
21st May 20247:00 amRNSStrategic alliance with p-Chip Corporation
15th May 20247:00 amRNSNew equity funding secured for £1,552,500
10th May 202411:47 amRNSPublication of the 2023 Annual Report and Accounts
9th May 20245:02 pmRNSIndependent Auditor's Report
1st May 20247:00 amRNS2023 Annual Report and Accounts
29th Apr 202412:27 pmRNSAgreement signed to launch a IM programme
5th Apr 20247:00 amRNSBusiness update
4th Apr 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.